Global Patent Index - EP 0996623 A1

EP 0996623 A1 2000-05-03 - 2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL

Title (en)

2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL

Title (de)

2,6-DI-T-BUTYL4-¬(DIMETHYL-4-METHOXYPHENYLSILYL)-METHYLOXY PHENOL UND 2,6-DI-T-BUTYL-4-¬(DIMETHYL-2-METHOXY-PHENYLSILYL)-METHYLOXY PHENOL

Title (fr)

2,6-DI-t-Butyl-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYL-OXY PHENOL ET 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL

Publication

EP 0996623 A1 (EN)

Application

EP 98923645 A

Priority

  • US 9810443 W
  • US 88184397 A

Abstract (en)

[origin: WO9858937A1] This invention relates to the compounds of 2,6-di-t-butyl-4- [(dimethyl-4- methoxyphenylsilyl)-methyloxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxyphenylsilyl)methyloxy]phenol, polymorphs thereof and their pharmaceutically acceptable salts, useful as antiatherosclerotic agents.

IPC 1-7 (main, further and additional classification)

C07F 7/08; A61K 31/695

IPC 8 full level (invention and additional information)

A61K 31/695 (2006.01); A61P 9/10 (2006.01); C07F 7/08 (2006.01)

CPC (invention and additional information)

C07F 7/0812 (2013.01)

Citation (search report)

See references of WO 9858937A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9858937 A1 19981230; AR 013115 A1 20001213; AU 7588498 A 19990104; CA 2295232 A1 19981230; EP 0996623 A1 20000503; JP 2002506443 A 20020226; ZA 9805324 B 19990107

INPADOC legal status


2007-11-14 [RTI1] TITLE (CORRECTION)

- Free text: 2,6-DI-T-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY PHENOL AND 2,6-DI-T-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY PHENOL

2006-12-29 [REG HK WD] APPLICATIONS WITHDRAWN, DEEMED TO BE WITHDRAWN, OR REFUSED AFTER PUBLICATION IN HONG KONG

- Document: HK 1029792

2003-02-05 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20020731

2002-05-08 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20020320

2000-05-17 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: AVENTIS PHARMACEUTICALS INC.

2000-05-03 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20000117

2000-05-03 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE